Journal
NATURE IMMUNOLOGY
Volume 14, Issue 8, Pages 812-+Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ni.2639
Keywords
-
Categories
Funding
- US National Institutes of Health [R01HL117334, R01AG032349, U24 AI082660, R01 AI079198, 5R01HL093262-02, 1R01HL112661-01, AI083713]
- American Heart Association [11POST7400075]
Ask authors/readers for more resources
Particulate ligands, including cholesterol crystals and amyloid fibrils, induce production of interleukin 1 beta (IL-1 beta) dependent on the cytoplasmic sensor NLRP3 in atherosclerosis, Alzheimer's disease and diabetes. Soluble endogenous ligands, including oxidized low-density lipoprotein (LDL), amyloid-beta and amylin peptides, accumulate in such diseases. Here we identify an endocytic pathway mediated by the pattern-recognition receptor CD36 that coordinated the intracellular conversion of those soluble ligands into crystals or fibrils, which resulted in lysosomal disruption and activation of the NLRP3 inflammasome. Consequently, macrophages that lacked CD36 failed to elicit IL-1 beta production in response to those ligands, and targeting CD36 in atherosclerotic mice resulted in lower serum concentrations of IL-1 beta and accumulation of cholesterol crystals in plaques. Collectively, our findings highlight the importance of CD36 in the accrual and nucleation of NLRP3 ligands from within the macrophage and position CD36 as a central regulator of inflammasome activation in sterile inflammation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available